GlassScriptPhysician profile
Francesca Panko
NPI 1639603830
$20,550.62
in general payments reported to CMS, 2019-2025
37 companies · $3,645 in 2025
The $3,645 reported for 2025 was more than what 97% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $5,785 · 2022: $3,770 · 2023: $4,334 · 2024: $3,017 · 2025: $3,645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,895 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,110 · Travel and Lodging: $910 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,895.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,110.00 |
| Travel and Lodging | $910.28 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $11,964.39 | 2021-2025 | Ofev, Stiolto Respimat, Jascayd |
| Astrazeneca Pharmaceuticals LP | $2,081.73 | 2021-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $707.34 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Actelion Pharmaceuticals US, INC. | $601.65 | 2021-2025 | Opsumit, Uptravi, Opsynvi |
| Amgen INC. | $555.69 | 2021-2025 | Tezspire, Otezla, Repatha |
| United Therapeutics Corporation | $541.35 | 2021-2025 | Tyvaso |
| Takeda Pharmaceuticals U.S.A., INC. | $535.52 | 2021-2025 | Glassia |
| Insmed, INC. | $512.38 | 2021-2025 | Arikayce |
| Inogen, INC. | $323.14 | 2022-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Philips North America LLC | $278.53 | 2021-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Regeneron Healthcare Solutions, INC. | $227.41 | 2022-2025 | Dupixent |
| Pulmonx Corporation | $225.20 | 2023-2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Mylan Specialty L.P. | $190.88 | 2021-2024 | Yupelri |
| Grifols USA, LLC | $164.40 | 2021-2023 | Prolastin-C Liquid |
| Baxter Healthcare | $163.34 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Advanced Respiratory, INC | $152.57 | 2021 | |
| Mallinckrodt Hospital Products INC. | $150.06 | 2021-2024 | Acthar |
| Novartis Pharmaceuticals Corporation | $137.80 | 2021-2025 | |
| Verona Pharma, INC. | $129.42 | 2025 | Ohtuvayre |
| Pfizer INC. | $125.09 | 2021-2025 | |
| Paratek Pharmaceuticals, INC. | $117.35 | 2021-2023 | Nuzyra |
| Genzyme Corporation | $107.46 | 2021-2022 | |
| Electromed, INC. | $98.70 | 2021-2025 | Smartvest |
| Merck Sharp & Dohme LLC | $84.34 | 2023-2024 | Winrevair, Keytruda |
| Vifor Pharma, INC. | $50.67 | 2024-2025 | Zemaira |
| Janssen Pharmaceuticals, INC | $48.56 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $43.63 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $38.25 | 2021 | |
| Ani Pharmaceuticals, INC. | $30.87 | 2023 | Purified Cortrophin Gel |
| Amarin Pharma, INC. | $27.73 | 2021 | |
| Inspire Medical Systems, INC. | $25.94 | 2024 | Inspire |
| Genentech USA, INC. | $22.00 | 2022 | |
| Melinta Therapeutics, LLC | $21.78 | 2021 | |
| Olympus America INC. | $18.95 | 2021 | |
| Astellas Pharma US INC | $18.79 | 2021 | |
| Novo Nordisk INC | $14.47 | 2021 | |
| Esperion Therapeutics, INC. | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francesca Panko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.